Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Bioxytran Inc (QB)
BIXT
Healthcare
Biotechnology
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke...
, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was founded in 2008 and is headquartered in Needham, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCQB:BIXT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(1)
•••
stock2watch1
X
Post by
stock2watch1
on Jul 25, 2025 11:54am
$BCTX Cancer Stock News Alert:
$BCTX Cancer Stock News Alert: BriaCell is giving two clinical data presentations at the European Society for Medical Oncology Congress 2025 Annual Meeting taking place in Berlin, Germany
...more
(1)
•••
christopher707
X
Post by
christopher707
on Mar 15, 2024 10:58am
Bioxytran ($BIXT): Redefining Healthcare through Innovation
Bioxytran, Inc. ($BIXT) is spearheading biotechnological advancements with its innovative approach to drug development. This groundbreaking platform extends beyond virology, addressing unmet medical
...more
Clean air specialist mitigating mercury emissions from US coal-fired power plants
posted Jan 22, 2026 9:00am by
Birchtech Corp.
-
|
The small-cap company, positioned for long-term growth with a profitable business and an ongoing expansion into water purification is eyeing an NYSE American listing ...read more
(1)
•••
christopher707
X
Post by
christopher707
on Mar 14, 2024 8:22am
Bioxytran's Innovative Approach to Drug Design
Bioxytran, Inc. ($BIXT) pioneers novel carbohydrate structures using AI to create rational drug designs. With a market cap of $19.53 million and 165.58 million outstanding shares, their leading
...more
(1)
•••
christopher707
X
Post by
christopher707
on Mar 12, 2024 11:07am
$BIXT: Pioneering AI-Driven Drug Design Innovations
Bioxytran, Inc. ($BIXT) stands at the forefront of biotechnology, leveraging artificial intelligence to revolutionise drug design. With a market cap of $19.04 million and 165.58 million outstanding
...more
(1)
•••
christopher707
X
Post by
christopher707
on Mar 11, 2024 8:00am
$BIXT Market Impact and Transformative Solutions Journey
Bioxytran ($BIXT) stands out with a market cap of $18.81 million and 165.58 million outstanding shares. Focused on glycovirology, hypoxia, and degenerative diseases, their innovative carbohydrate drug
...more
(1)
•••
christopher707
X
Post by
christopher707
on Mar 08, 2024 7:04am
$BIXT:Revolutionising Healthcare with Cutting-Edge Solutions
In the ever-evolving landscape of healthcare, Bioxytran stands out with a market cap of $19.87 million. As an OTC-listed company under the symbol $BIXT, it boasts 165.59 million outstanding shares
...more
(1)
•••
christopher707
X
Post by
christopher707
on Mar 07, 2024 8:04am
Bioxytran ($BIXT): Resilient Growth in Pharmaceuticals
With a market cap of $19.87 million and 165.59 million outstanding shares, Bioxytran ($BIXT) is a force in pharmaceuticals. Averaging a 30-day volume of 62,545 and boasting a 52-week range of $0.071
...more
(18)
•••
lelianicruz
X
Post by
lelianicruz
on Mar 05, 2024 10:34am
$BIXT : A Promising Player in Pharmaceuticals
With a market cap of $18.4M and a current price of $0.1113, Bioxytran ( $BIXT ) stands out as a significant contender in the pharmaceutical sector. Their focus on addressing critical medical
...more
(0)
•••
amritadanique
X
Post by
amritadanique
on Oct 27, 2023 8:02am
Bioxytran, Inc. ($BIXT): Leading Healthcare Innovation!
Bioxytran, Inc. ($BIXT) boasts a market capitalization of $21.74 million and a strong 30-day average volume of 117,188, underscoring its presence in the healthcare landscape. As a biotech pioneer
...more
(0)
•••
amritadanique
X
Post by
amritadanique
on Oct 26, 2023 8:58am
"$BIXT Valuation Highlights Promising Biotech Potential"
The present market capitalization of Bioxytran, Inc. ($BIXT) stands at $23.09 million, reflecting its promising potential in the biotech industry. This valuation underscores the company's
...more
(0)
•••
amritadanique
X
Post by
amritadanique
on Oct 25, 2023 10:00am
$BIXT: Transforming Healthcare with Innovation
Bioxytran, Inc. ($BIXT) is a leading force in healthcare innovation, with a remarkable market capitalization exceeding $24.5 million and solid support from over 144 million outstanding shares. Their
...more
(0)
•••
amritadanique
X
Post by
amritadanique
on Oct 24, 2023 11:48am
Bioxytran: Leading Healthcare Innovation Efforts
With a market capitalization of over $24.4 million and a remarkable 144,355,355 outstanding shares, Bioxytran is making substantial strides in the biotech industry. Their focus on tackling critical
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 24, 2023 8:45am
New Press Release - Bioxytran Gets Broad Patent Coverage on 60+ Viruses
Claims cover method of treating a viral infection with a lectin-binding carbohydrate BOSTON, MASSACHUSETTS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral...
read article.
(0)
•••
amritadanique
X
Post by
amritadanique
on Oct 20, 2023 7:10am
$BIXT: Transforming Healthcare with Innovative Solutions
Bioxytran, Inc. ($BIXT) is a pioneering force in healthcare, focused on combating hypoxia with innovative pharmaceutical solutions. Their robust market capitalization, exceeding $24.5 million, and 144
...more
(0)
•••
amritadanique
X
Post by
amritadanique
on Oct 19, 2023 7:31am
$BIXT: Pioneering Growth and Innovation in Biotech
Bioxytran, Inc. ($BIXT) stands as a compelling presence in the biotech industry with remarkable statistics. Their market capitalization, exceeding $24 million, combined with 144 million+ outstanding
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A clean tech company on the verge of transformational growth plans to uplist to major US exchange
Vertical integration could reshape this scaling beverage brand’s long-term outlook
A transformational year in 2025 and positive outlook for growth in revenue and profitability in 2026
Podcasts